![]() | BlueOcean (BOV) |
BlueOcean is a tokenized medtech VC fund.
Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is BlueOcean
The overall aim of medtech is to not only prevent disease and death but pre-empt and address new and existing conditions that are affecting human beings. Medtech is the union of the medical field, technology and large amounts of data that are being generated about patients and the diseases they exhibit. The medtech field covers both medical devices as well as in vitro (meaning: in the glass) diagnostic medical devices, processes and procedures.
Medtech covers a wide array of devices and applications including familiar, household goods such as syringes and spectacles through to high-tech applications such as molecular diagnostics and implantable devices such as heart valves. There is no living human that has not interacted with thousands of medtech devices over their lifetime or even on a daily basis.
According to the European Medical Technology Industry report of 2018, “There are more than 500,000 medical technologies currently available and they all share a common purpose: improving, extending and transforming people’s lives.”
BlueOcean Roadmap
Launch of BlueOcean Ventures I
Launch of BlueOcean Ventures II
BlueOcean Ventures II invests in Abionic, Rheon Medical and Ava
STO Platform SwissVCToken is set up in Singapore
BlueOcean Ventures II invests in Volumina Medical SA and Luciole Medicale AG
Start of STO Pre Sale
BlueOcean Ventures II has a portfolio of 6 startups
Start of Security Token offering Main Sale
End of STO: 100% of STO net proceeds are invested into BlueOcean Ventures II
BOV Tokens are traded on several exchanges. First NAV of SwissVCToken is communicated
Blue Ocean Ventures II has a portfolio of 8 to 12 startups
First Portfolio Company is sold, triggering a first pay-out of investors.
Pay-out received by SwissVCToken are distributed 100% to Token Holders
Remaining Portfolio Companies are sold
Pay-out received by SwissVCToken are 100%distributed to Token Holders
BlueOcean Ventures II is closed. All remaining assests are distributed to investors
Pay-out received by SwissVCToken are 100%distributed to Token Holders
Token Sale Dates
ICO
Token Allocation
Restrictions
China, Iran, North Korea
Token Price and Payment Options
Project team






Advisors















